Temozolomide

Temozolomide is a cancer drug used to treat certain types of brain cancer and skin cancer. It works by stopping the growth of cancer cells. It's typically given in cycles.

Brand names:Temodal, Temodar
Medication

What people taking Temozolomide report

Every report comes from a Lived member, sent anonymously.

Have you tried Temozolomide for Glioblastoma?

NameHow it went

About Temozolomide

What It's For

Temozolomide, sold in the United States as Temodar and in Europe as Temodal, is a chemotherapy medicine used to treat certain malignant brain tumors in adults. Unlike most chemotherapy, it is usually taken as capsules at home. Its main use is for glioblastoma, the most common and most aggressive brain tumor that starts in the brain itself. After surgery removes as much of the tumor as is safely possible, temozolomide is taken every day during about six weeks of radiation therapy and then on its own in monthly cycles. It is also approved for anaplastic astrocytoma, another malignant glioma (a tumor that grows from the brain's supporting cells), both after radiation for a newly diagnosed tumor and when the tumor has grown despite other treatment. Researchers are studying it in other cancers as well.

How It Works

Cancer cells divide more often than most healthy cells, and every division requires copying their DNA. Once in the body, temozolomide converts into a reactive compound that attaches small chemical groups to DNA. The damaged DNA breaks when the cell tries to copy it, and the cell dies. Some tumors make a repair protein called MGMT that removes this damage, which blunts the drug's effect. In many glioblastomas the gene for MGMT is switched off (described on a pathology report as a methylated MGMT promoter). These tumors cannot repair the damage as easily, and in the landmark trial they were the ones that drew clear benefit from temozolomide. For that reason, MGMT testing on the tumor sample often shapes how the oncology team discusses expected benefit.

Dosage & Administration

The dose is calculated from body size (height and weight) and then adjusted according to blood counts and side effects. For newly diagnosed glioblastoma, a lower daily dose is taken every day throughout radiation therapy. About four weeks after radiation ends, a higher dose is taken on days 1 to 5 of each 28-day cycle, typically for six cycles. For anaplastic astrocytoma, the same five-days-on schedule is used, often for up to 12 cycles after radiation. A full dose may combine capsules of different strengths, so it helps to know what each one looks like. Take it at the same time each day and in the same way relative to food. Taking it on an empty stomach or at bedtime, with an anti-nausea medicine beforehand, reduces nausea. Swallow the capsules whole with water. Never open, chew or dissolve them: the powder is a hazardous drug, and if a capsule breaks, avoid touching or breathing it and wash any skin it touches right away. If you vomit after a dose, do not take another that day; tell the care team. An intravenous form exists for people who cannot take capsules.

Side Effects

Hair loss, tiredness, nausea, vomiting, constipation, loss of appetite and headache are the most common side effects. Nausea is usually manageable with anti-nausea medicine taken before each dose. Seizures are also common in people being treated for brain tumors and often reflect the tumor itself; any new or more frequent seizures should be reported promptly. The most important serious effect is a drop in blood counts. Low white cells make infections more likely, and low platelets make bleeding easier. Counts usually reach their lowest about three to four weeks into a cycle, and older adults and women are more likely to be affected. Contact the care team right away for a fever, chills or other signs of infection, unusual bleeding or bruising, new or worsening cough or shortness of breath, or yellowing of the skin or eyes.

Interactions & Warnings

Temozolomide can seriously harm a developing baby. A pregnancy test is done before starting. Women who could become pregnant should use effective birth control during treatment and for six months after the last dose, and men with a partner who could become pregnant should use condoms during treatment and for three months after. Men should not donate semen during that time, and the drug may reduce male fertility, so banking sperm is worth discussing before starting. Breastfeeding should stop during treatment and for one week afterward. Steroids such as dexamethasone, often used to reduce brain swelling, raise the risk of Pneumocystis pneumonia (PCP), a lung infection that takes hold when immunity is low. A preventive antibiotic is given throughout chemoradiation and longer if lymphocyte counts (a type of white blood cell) stay low. Rare severe liver injury has been reported, so liver tests are done before and during treatment and a few weeks after it ends. People who have had a serious allergic reaction to temozolomide or to dacarbazine, a related chemotherapy that breaks down into the same active compound, should not take it. Like other chemotherapy that damages DNA, it slightly raises the chance of a later blood cancer such as myelodysplastic syndrome or leukemia. Tell the care team about all other medicines and supplements before starting.

What to Expect

Treatment follows a predictable rhythm. During radiation, there are daily capsules and weekly blood counts. Maintenance cycles bring five days of capsules followed by about three weeks off, with blood tests around day 22 and before each new cycle. If counts have not recovered, the next cycle is delayed or the dose is lowered; this is routine and does not mean treatment has failed. Tiredness is the most common complaint through both phases. Temozolomide does not cure glioblastoma, but it extends life. In the trial that established it, median survival rose from about 12 months with radiation alone to about 15 months with temozolomide added. Benefit is usually greater when the tumor's MGMT gene is switched off. Regular MRI scans track the tumor, and the oncology team decides whether to continue, change or stop treatment based on scans, blood counts and how a person is managing day to day.

Questions to Ask Your Doctor

  1. 1.Was my tumor tested for MGMT methylation, and what does the result mean for how much temozolomide is likely to help?
  2. 2.How many cycles do you expect me to take, and what would make us stop early or change treatment?
  3. 3.Which blood tests will I need, and what fever or other symptoms should make me call you, including after hours?
  4. 4.Which anti-nausea medicine and preventive antibiotic will I take, and how do the steroids I am on affect my risks?
  5. 5.Should I think about sperm banking or egg preservation before I start, and what birth control should I use and for how long?

Last reviewed • Oct 2026

Educational content, not medical advice.